$5.96
-0.20-3.25%
At close: -
$5.90
-0.06-1.01%
After Hours: Feb 21, 7:21 PM EDT
Comments
Loading...
Jasper Therapeutics (JSPR) Forecast
NewsEarningsJasper Therapeutics (JSPR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestJasper Therapeutics (NASDAQ:JSPR) Stock Quotes, Forecast and News Summary
Jasper Therapeutics Stock (NASDAQ: JSPR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Jasper Therapeutics (JSPR) stock?
You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.
Who are Jasper Therapeutics (JSPR) competitors?
Other companies in Jasper Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Skye Bioscience (NASDAQ:SKYE), Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX) and Galectin Therapeutics (NASDAQ:GALT).
What is the forecast, or price target, for Jasper Therapeutics (JSPR) stock?
Jasper Therapeutics has a consensus price target of $46.76.
What is the current price for Jasper Therapeutics (JSPR)?
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $5.9 last updated February 21, 2025 at 7:21 PM EST.
Does Jasper Therapeutics (JSPR) pay a dividend?
There are no upcoming dividends for Jasper Therapeutics.
When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?
Jasper Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Jasper Therapeutics (JSPR) going to split?
There is no upcoming split for Jasper Therapeutics.
What sector and industry does Jasper Therapeutics (JSPR) operate in?
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.